Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

After publication of the Original research article [1] it was brought to our attention that the sentence at pag 6 (between Figure 3 and Figure 4)) must be corrected as follows: “The mean duration of inactivity was 2.88 (0.63) at baseline; 1.53 (0.27) after 3; 1.40 (0.27) after 6, and 1.45 days (0.58...

Full description

Bibliographic Details
Main Authors: Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
Format: Article
Language:English
Published: PAGEPress Publications 2018-07-01
Series:Multidisciplinary Respiratory Medicine
Online Access:http://link.springer.com/article/10.1186/s40248-018-0144-5
id doaj-e694f7889b2840baabbe9e979852d1c9
record_format Article
spelling doaj-e694f7889b2840baabbe9e979852d1c92020-11-25T01:37:46ZengPAGEPress PublicationsMultidisciplinary Respiratory Medicine2049-69582018-07-011311110.1186/s40248-018-0144-5Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthmaRoberto W. Dal Negro0Luca Bonadiman1Paola Turco2National Centre for Respiratory Pharmacoeconomics and PharmacoepidemiologyNational Centre for Respiratory Pharmacoeconomics and PharmacoepidemiologyResearch & Clinical GovernanceAfter publication of the Original research article [1] it was brought to our attention that the sentence at pag 6 (between Figure 3 and Figure 4)) must be corrected as follows: “The mean duration of inactivity was 2.88 (0.63) at baseline; 1.53 (0.27) after 3; 1.40 (0.27) after 6, and 1.45 days (0.58) after twelve months (Anova: p = 0.11) in group A, while the corresponding duration in group B was 3.35 (0.63) at baseline; 0.60 (0.19) after 3; 1.10 (0.21) after 6, and 0.83 days (0.39) after 12 months (Anova; p <0.001), respectively.”http://link.springer.com/article/10.1186/s40248-018-0144-5
collection DOAJ
language English
format Article
sources DOAJ
author Roberto W. Dal Negro
Luca Bonadiman
Paola Turco
spellingShingle Roberto W. Dal Negro
Luca Bonadiman
Paola Turco
Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
Multidisciplinary Respiratory Medicine
author_facet Roberto W. Dal Negro
Luca Bonadiman
Paola Turco
author_sort Roberto W. Dal Negro
title Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_short Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_full Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_fullStr Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_full_unstemmed Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_sort correction to: fluticasone furoate/vilanterol 92/22 μg once-a-day vs beclomethasone dipropionate/formoterol 100/6 μg b.i.d.: a 12-month comparison of outcomes in mild-to-moderate asthma
publisher PAGEPress Publications
series Multidisciplinary Respiratory Medicine
issn 2049-6958
publishDate 2018-07-01
description After publication of the Original research article [1] it was brought to our attention that the sentence at pag 6 (between Figure 3 and Figure 4)) must be corrected as follows: “The mean duration of inactivity was 2.88 (0.63) at baseline; 1.53 (0.27) after 3; 1.40 (0.27) after 6, and 1.45 days (0.58) after twelve months (Anova: p = 0.11) in group A, while the corresponding duration in group B was 3.35 (0.63) at baseline; 0.60 (0.19) after 3; 1.10 (0.21) after 6, and 0.83 days (0.39) after 12 months (Anova; p <0.001), respectively.”
url http://link.springer.com/article/10.1186/s40248-018-0144-5
work_keys_str_mv AT robertowdalnegro correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma
AT lucabonadiman correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma
AT paolaturco correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma
_version_ 1725057557568946176

Similar Items